Maher Masoud

Maher Masoud

President and Chief Executive OfficeratMaxcyte· In proxies 2022–2025

Pay in FY2025-26% from the year before · Maxcyte stock -62.7% the same year

Maher Masoud was paid $2.7M in FY2025 (Dec), down 26%. Maxcyte stock fell 62.7% that year.

Pay$100 in the stock at the end of FY21 → $15
Pay is from the Summary Compensation Table of each Maxcyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MaxcytePublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role -83%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?